The Global Surgical Sutures Market Size is projected to grow at a CAGR of 7.57% during the forecast period from 2026 to 2034 | DelveInsight

The Surgical Sutures market is estimated at USD 6.03 billion in 2025 and is projected to reach USD 11.52 billion by 2034. Growth is anchored by the rising global volume of surgical procedures, increasing prevalence of chronic wounds and traumatic injuries, expanding adoption of minimally invasive and robotic-assisted surgery requiring advanced wound closure solutions, and continuous product innovation, including antimicrobial, absorbable, and barbed sutures.

DelveInsight's Surgical Sutures Market Insights Report 2034 provides the current and forecast market analysis, individual leading Surgical Sutures companies' market shares, challenges, Surgical Sutures Market Drivers, barriers, trends, and key market Surgical Sutures companies in the market.

To read more about the latest highlights related to the Surgical Sutures Market @
https://www.delveinsight.com/report-store/surgical-sutures-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Key Takeaways from the Surgical Sutures Market Report

• In January 2026, Suturion's SutureTOOL received US FDA clearance as a first-of-its-kind device designed to standardize precise abdominal wall closures. Strategic significance: Brings device-assisted standardization to a step of surgery that has historically relied entirely on manual technique.
• In December 2025, Teleflex Incorporated announced definitive agreements to divest its Teleflex Medical OEM business, which manufactures surgical fibers and sutures, to Montagu and Kohlberg in a carve-out transaction valued at roughly USD 1.5 billion, alongside a separate USD 530 million sale of its acute care and interventional urology businesses, with closing expected in the second half of 2026. Strategic significance: Reshapes the competitive supplier base for contract-manufactured surgical fibers and sutures and signals continued portfolio realignment among diversified medtech suppliers.
• Medical Microinstruments, Inc. launched the MMI Robotic Suture globally, the world's first suture purpose-built for its Symani Surgical System, tailored for delicate microsurgery. Strategic significance: Extends suture innovation directly into the fast-growing robotic microsurgery segment.
• The global Surgical Sutures market is growing at a CAGR of 7.57% during the forecast period from 2026 to 2034.
• The principal drivers are the rising global volume of surgical procedures; the growing burden of chronic and cardiovascular disease; an expanding geriatric population with rising age-related surgical needs; continued technological advancement in suture materials and coatings; rapid adoption of barbed, knotless suture technology; growth of minimally invasive and robot-assisted surgery; and expansion of ambulatory surgical centers and outpatient procedures.
• The leading Surgical Sutures Companies include Johnson & Johnson (Ethicon), Medtronic PLC, B. Braun Melsungen AG, Smith & Nephew, Boston Scientific Corporation, DemeTECH Corporation, Internacional Farmacéutica S.A. de C.V., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, and Lotus Surgicals, among others.

To know more about why North America is leading the market growth in the Surgical Sutures Market, Get a snapshot @
https://www.delveinsight.com/report-store/surgical-sutures-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Surgical Sutures Overview

A surgical suture is a sterile medical device, typically a threaded needle-and-filament system, used by surgeons to approximate and hold together tissue, close surgical incisions, and ligate blood vessels following surgery, trauma, or injury. Sutures are foundational to wound closure across virtually every surgical discipline and remain the benchmark against which newer closure technologies, including staples, adhesives, and mechanical closure devices, are measured. The market spans suturing devices and suture threads, the latter split into absorbable and non-absorbable materials; natural fibers such as silk and catgut and synthetic polymers such as polyglactin, polydioxanone, and polypropylene; monofilament, multifilament, and barbed constructions; and applications led by general, cardiovascular, orthopedic, ophthalmic, and gynecological surgery across hospitals, specialty clinics, and ambulatory surgical centers.

Surgical Sutures Market Key Growth Drivers

• The rising global volume of surgical procedures is a direct driver, with roughly 600,000 knee replacements and about 200,000 coronary artery bypass graft procedures performed annually in the United States alone.
• The growing global burden of chronic and cardiovascular disease is expanding demand for surgical intervention, with the WHO attributing 17.9 million deaths in 2019 to cardiovascular disease, the leading cause of major surgical referral.
• An expanding geriatric population is increasing rates of hip and knee replacement, hernia repair, and cardiovascular procedures that rely heavily on suture-based wound closure.
• Continuous technological advancement, including antibacterial triclosan-coated sutures now recommended by the CDC, WHO, and the American College of Surgeons and Surgical Infection Society for reducing surgical site infection, is broadening premium-suture adoption.
• Rapid adoption of barbed, knotless suture technology is reducing operative time and knot-related complications across cosmetic, orthopedic, and gynecological procedures.
• The continued shift toward minimally invasive and robot-assisted surgery is increasing demand for fine-gauge, high-performance sutures engineered for small-incision handling and robotic compatibility.
• The rapid growth of ambulatory surgical centers and outpatient procedure volumes, particularly across the US, China, and India, is broadening and decentralizing the demand base for surgical sutures.

Get a sneak peek at the Surgical Sutures Market Dynamics @
https://www.delveinsight.com/report-store/surgical-sutures-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Surgical Sutures Market Segment Analysis

The Surgical Sutures Market by Product Type (Suturing Devices, Suture Threads [Absorbable and Non-Absorbable]), Suture Type (Natural and Synthetic), Suture Filament (Monofilament, Multifilament, and Barbed), Application (General Surgery, Cardiovascular Surgery, Orthopedic Surgery, Ophthalmic Surgery, Gynecological Surgery, and Others), End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).
• By product type, suture threads led the market with 79% share in 2025, since they are the direct, consumable component replaced with every procedure, while suturing devices are durable equipment purchased far less frequently.
• By suture type, synthetic sutures led with 85% share in 2025, given their predictable, manufacturer-controlled tensile strength retention and absorption profiles compared with natural materials.
• By suture filament, multifilament sutures led with 52% share in 2025, owing to their superior flexibility and knot security across general, gynecological, and soft-tissue procedures, though barbed sutures are the fastest-growing filament type.
• By application, general surgery led with 34% share in 2025, reflecting its breadth of high-volume procedures performed across virtually every hospital and surgical center.
• By end-user, hospitals led with 68% share in 2025, given their high-acuity caseloads and purchasing scale across the full range of suture products.
• North America led global revenue with 39% share in 2025, the largest of any region, while Asia-Pacific is the fastest-growing region, driven by rising surgical volumes and expanding regional manufacturing capacity.

Which MedTech key players in the Surgical Sutures Market are set to emerge as the trendsetter explore @
https://www.delveinsight.com/report-store/surgical-sutures-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Surgical Sutures Market Competitive Landscape

The Surgical Sutures market is classified as Moderately Consolidated. Johnson & Johnson, along with Medtronic, B. Braun Melsungen AG, Smith & Nephew, and Boston Scientific, anchor the top tier through broad product portfolios, global manufacturing scale, and deep hospital distribution relationships, while specialized and fast-scaling manufacturers such as DemeTECH Corporation, Meril Life Sciences, Teleflex Incorporated, Internacional Farmacéutica, and Lotus Surgicals compete through cost efficiency, regional manufacturing depth, and targeted product innovation, increasing competition across both developed and emerging markets.

Surgical Sutures Companies

• Johnson & Johnson (Ethicon)
• Medtronic PLC
• B. Braun Melsungen AG
• Smith & Nephew
• Boston Scientific Corporation
• DemeTECH Corporation
• Internacional Farmacéutica S.A. de C.V.
• Meril Life Sciences Pvt. Ltd.
• Teleflex Incorporated
• Lotus Surgicals
• and others.

Surgical Sutures Market Restraints

• Despite steady momentum, the Surgical Sutures market faces material constraints. The global shift toward alternative wound closure technologies, including surgical staples, tissue adhesives, and mechanical closure devices, is displacing sutures in select applications where speed and ease of use are prioritized over the tensile strength and versatility of thread-based closure.
• Pricing pressure from a highly fragmented base of regional and low-cost manufacturers, particularly across India, Turkey, and China, is compressing margins for global brands.
• Stringent regulatory requirements for medical device approval, sterilization validation, and biocompatibility testing lengthen product development timelines and raise costs, especially for antimicrobial and bioresorbable innovations.
• The high cost of antimicrobial and barbed sutures relative to conventional products limits accessibility in price-sensitive healthcare systems, while reimbursement structures in several emerging markets remain uneven.
• The risk of surgical site infection and suture-related complications continues to draw clinical and regulatory scrutiny, and antimicrobial resistance concerns pose a long-term challenge to antibacterial-coated suture technology.

Interested in knowing the Surgical Sutures Market by 2034? Click to get a snapshot of the Surgical Sutures Market Trends-
https://www.delveinsight.com/report-store/surgical-sutures-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Scope of the Surgical Sutures Market Report

• Coverage- Global
• Forecast Period- 2026-2034
• Surgical Sutures Companies- Johnson & Johnson (Ethicon), Medtronic PLC, B. Braun Melsungen AG, Smith & Nephew, Boston Scientific Corporation, DemeTECH Corporation, Internacional Farmacéutica S.A. de C.V., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, Lotus Surgicals, and others.
• Surgical Sutures Market Restraints and Regulatory Analysis
• Surgical Sutures Porter Five Forces Analysis and Market Assessment

Explore more information of the Surgical Sutures Market Insights @
https://www.delveinsight.com/report-store/surgical-sutures-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Table of Contents

• Surgical Sutures Market Report Introduction
• Surgical Sutures Market Executive Summary
• Surgical Sutures Market Key Factors Analysis
• Impact Analysis: AI, Geopolitical, Trade, and Economic Developments
• Regulatory Analysis
• Surgical Sutures Market Porter's Five Forces Analysis
• Surgical Sutures Market Assessment
• Surgical Sutures Market Competitive Landscape
• Surgical Sutures Market Startup Funding and Investment Trends
• Surgical Sutures Market Company and Product Profiles
• KOL Views
• Project Approach
• About DelveInsight
• Disclaimer and Contact Us

Company Name: DelveInsight Business Research LLP
Contact Person: Kanishk Kumar
Email: info@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

This release was published on openPR.